BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34948029)

  • 1. Effects and Related Mechanisms of the Senolytic Agent ABT-263 on the Survival of Irradiated A549 and Ca9-22 Cancer Cells.
    Sato K; Iwasaki S; Yoshino H
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.
    González-Gualda E; Pàez-Ribes M; Lozano-Torres B; Macias D; Wilson JR; González-López C; Ou HL; Mirón-Barroso S; Zhang Z; Lérida-Viso A; Blandez JF; Bernardos A; Sancenón F; Rovira M; Fruk L; Martins CP; Serrano M; Doherty GJ; Martínez-Máñez R; Muñoz-Espín D
    Aging Cell; 2020 Apr; 19(4):e13142. PubMed ID: 32233024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Senolytic effects on dental pulp stem cell's proliferation and differentiation during long-term expansion].
    Wang GY; Liao L; Tian WD
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2024 May; 59(5):444-452. PubMed ID: 38636998
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
    Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
    Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin.
    Ahmadinejad F; Bos T; Hu B; Britt E; Koblinski J; Souers AJ; Leverson JD; Faber AC; Gewirtz DA; Harada H
    Mol Pharmacol; 2022 Mar; 101(3):168-180. PubMed ID: 34907000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
    Hoque MM; Iida Y; Kotani H; Harada M
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cancer SENESCopedia: A delineation of cancer cell senescence.
    Jochems F; Thijssen B; De Conti G; Jansen R; Pogacar Z; Groot K; Wang L; Schepers A; Wang C; Jin H; Beijersbergen RL; Leite de Oliveira R; Wessels LFA; Bernards R
    Cell Rep; 2021 Jul; 36(4):109441. PubMed ID: 34320349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263.
    Abdelgawad IY; Agostinucci K; Ismail SG; Grant MKO; Zordoky BN
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of radiation-induced micronuclei associated with premature senescence, and their selective removal by senolytic drug, ABT-263.
    Suzuki K; Kawamura K; Ujiie R; Nakayama T; Mitsutake N
    Mutat Res Genet Toxicol Environ Mutagen; 2022; 876-877():503448. PubMed ID: 35483779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patients.
    Miura Y; Endo K; Komori K; Sekiya I
    Stem Cell Res Ther; 2022 Jun; 13(1):222. PubMed ID: 35658936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice.
    Pan J; Li D; Xu Y; Zhang J; Wang Y; Chen M; Lin S; Huang L; Chung EJ; Citrin DE; Wang Y; Hauer-Jensen M; Zhou D; Meng A
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):353-361. PubMed ID: 28479002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs.
    Chang M; Gao F; Gnawali G; Xu H; Dong Y; Meng X; Li W; Wang Z; Lopez B; Carew JS; Nawrocki ST; Lu J; Zhang QY; Wang W
    J Med Chem; 2024 May; 67(9):7301-7311. PubMed ID: 38635879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-X
    Saleh T; Carpenter VJ; Tyutyunyk-Massey L; Murray G; Leverson JD; Souers AJ; Alotaibi MR; Faber AC; Reed J; Harada H; Gewirtz DA
    Mol Oncol; 2020 Oct; 14(10):2504-2519. PubMed ID: 32652830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury.
    Lim S; Kim TJ; Kim YJ; Kim C; Ko SB; Kim BS
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and Cellular Characterization of New Radio-Resistant Cell Lines Reveals a Role of Natural Flavonoids to Bypass Senescence.
    Russo M; Spagnuolo C; Moccia S; Tedesco I; Lauria F; Russo GL
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.
    Fletcher-Sananikone E; Kanji S; Tomimatsu N; Di Cristofaro LFM; Kollipara RK; Saha D; Floyd JR; Sung P; Hromas R; Burns TC; Kittler R; Habib AA; Mukherjee B; Burma S
    Cancer Res; 2021 Dec; 81(23):5935-5947. PubMed ID: 34580063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABT-263 induces G
    Lin QH; Que FC; Gu CP; Zhong DS; Zhou D; Kong Y; Yu L; Liu SW
    Acta Pharmacol Sin; 2017 Dec; 38(12):1632-1641. PubMed ID: 28713162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of senolytic drugs on human mesenchymal stromal cells.
    Grezella C; Fernandez-Rebollo E; Franzen J; Ventura Ferreira MS; Beier F; Wagner W
    Stem Cell Res Ther; 2018 Apr; 9(1):108. PubMed ID: 29669575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
    Shahbandi A; Rao SG; Anderson AY; Frey WD; Olayiwola JO; Ungerleider NA; Jackson JG
    Cell Death Differ; 2020 Nov; 27(11):3097-3116. PubMed ID: 32457483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
    Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
    Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.